Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Infection
79%
SARS Coronavirus
49%
Arthralgia
49%
Defined Daily Dose
39%
Drug Utilization
39%
Nootropic Agent
39%
Syndrome
39%
Thrombocytopenia
39%
Thromboembolism
39%
Alendronic Acid
39%
Thrombosis
39%
Gastrointestinal Symptom
39%
Asthma
39%
Bisphosphonic Acid Derivative
29%
Parathyroid hormone[1-34]
29%
Denosumab
29%
Drug Information
19%
Selective Estrogen Receptor Modulator
19%
Depressive Disorder
19%
Diseases
19%
Messenger RNA
14%
Vein Thrombosis
9%
Adenoviridae
9%
Muscle Spasm
9%
Headache
9%
Cognitive Defect
9%
Coughing
9%
Abdominal Pain
9%
Sleep Disorder
9%
Random Effects Model
9%
Treatment Group
9%
Chronic Obstructive Lung Disease
8%
Memantine
5%
Galantamine
5%
Rivastigmine
5%
Donepezil
5%
Comorbidity
5%
Medicine and Dentistry
COVID-19
87%
Cohort Analysis
48%
Rheumatoid Arthritis
39%
Hydroxychloroquine
39%
Nootropic Agent
39%
Retrospective Cohort Study
39%
Inflammatory Arthritis
39%
Latent Class Analysis
39%
Hazard Ratio
23%
Infection
18%
Primary Health Care
15%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Arthralgia
9%
Electronic Patient Record
7%
Proportional Hazards Model
7%
Rheumatology
7%
Drug Megadose
7%
Gastrointestinal Distress
6%
Health Care
6%
Cluster Analysis
6%
Cohort Effect
6%
Depressive Disorder
6%
Rivastigmine
5%
Galantamine
5%
Donepezil
5%
Memantine
5%
Comorbidity
5%
Neuroscience
Donepezil
53%
Memantine
53%
Rivastigmine
53%
Rheumatoid Arthritis
39%
Galantamine
39%
Alzheimer's Disease
39%
Suicidal Ideation
39%
Hydroxychloroquine
39%
Comorbidity
39%
Acetylcholinesterase Inhibitor
13%
Dextro Aspartic Acid
13%
Coronavirus
7%
Coronavirinae
7%
Rheumatology
7%